Dyne Therapeutics Inc. (DYN)
Market Open
11 Sep, 14:01
NASDAQ (NGS) NASDAQ (NGS) Primary $
18. 30
-0.12
-0.6515%
$
3.79B Market Cap
- P/E Ratio
- Div Yield
154,724 Volume
-3.29 Eps
$ 18.42
Previous Close 
Want to track DYN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Dyne Therapeutics Inc. (DYN) Statistics
Valuation metrics
Market Cap 3.79B
Enterprise value 3.88B
Trailing P/E (ttm) -7.29
Forward P/E -
PEG ratio -0.51
Price/Sales (ttm) -
Price/Book (mrq) 5.72
Enterprise Value/Revenue -
Enterprise Value/EBITDA -7.83
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.46M
Average volume (90 days) 2.02M
Price summary
52-Week low 11.92
52-Week high 27.3
Beta -
50-Day moving average 25.84
200-Day moving average 18.35
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.52%
Return on equity -0.64%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.43
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 12.02%
Book value per share (mrq) 4.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
